Accounting for Competing Risks in Clinical Research
JAMA · 25.06.2024 · 331 (24) · 2125
DOI: 10.1001/jama.2024.4970 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA, erschienen am 25.06.2024. Verfasst von Peter C Austin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Biomedical Research, Clinical Trials as Topic, Risk. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: CIHR.
Abstract (Originalsprache)
This JAMA Guide to Statistics and Methods article discusses accounting for competing risks in clinical research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute for Clinical Evaluative Sciences (ICES), Toronto, Ontario, Canada.
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
- Sunnybrook Research Institute, Toronto, Ontario, Canada.
- NHS Blood and Transplant, Bristol, United Kingdom.
- Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.
Förderung
- CIHR
Zitieren
APA
Austin, P. C., Ibrahim, M., & Putter, H. (2024). Accounting for Competing Risks in Clinical Research. JAMA, 331(24), 2125. https://doi.org/10.1001/jama.2024.4970
Vancouver
Austin PC, Ibrahim M, Putter H. Accounting for Competing Risks in Clinical Research. JAMA. 2024;331(24):2125. doi:10.1001/jama.2024.4970
BibTeX
@article{Austin2024,
author = {Austin, Peter C and Ibrahim, Maria and Putter, Hein},
title = {Accounting for Competing Risks in Clinical Research},
journal = {JAMA},
year = {2024},
volume = {331},
number = {24},
pages = {2125},
doi = {10.1001/jama.2024.4970}
}
EUVIMED